Clinical Trial Update: Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase I study evaluating HSK46575 in patients with metastatic castration-resistant prostate cancer; recruitment is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• HSK46575

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: m CRPC | Phase 1 | Status: RECRUITING